{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:32:21Z","timestamp":1793694741909,"version":"4.5.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.bioadv.2026.215251","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:53:54Z","timestamp":1792047234000},"page":"215251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PEGylated fucoxanthin liposomes remodel G0\/G1 cell cycle homeostasis and suppress gallbladder cancer progression via modulation of NR2F1-mediated signaling networks"],"prefix":"10.1016","volume":"191","author":[{"given":"Jun-Feng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengliang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunshui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer. Nature reviews","volume":"8","author":"Roa","year":"2022","journal-title":"Disease Primers"},{"issue":"22","key":"10.1016\/j.bioadv.2026.215251_bb0010","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bioadv.2026.215251_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126368","article-title":"Targeted inhibition of gastric adenocarcinoma by nano-curcumin liposomes: insights from combined machine learning and experimental analyses into the mechanisms of cuproptosis and metabolic reprogramming","volume":"686","author":"Cao","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215251_bb0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.suc.2024.03.006","article-title":"Gallbladder Cancer","volume":"104","author":"Waller","year":"2024","journal-title":"Surg. Clin. North Am."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations","volume":"8","author":"Schmidt","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2026.215251_bb0030","doi-asserted-by":"crossref","DOI":"10.2174\/0118715206436002260402044851","article-title":"Design of receptor-specific anticancer agents for gallbladder cancer: integrating immunomodulatory strategies","author":"Verma","year":"2026","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bioadv.2026.215251_bb0035","article-title":"Molecular pathogenesis of gallbladder cancer: an update","volume":"816\u2013818","author":"Mishra","year":"2019","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bioadv.2026.215251_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113564","article-title":"Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: current advancements and future perspectives","volume":"199","author":"Ten Haaft","year":"2024","journal-title":"Eur. J. Cancer (Oxford, England: 1990)"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12029-026-01423-z","article-title":"cGAS-STING pathway in gastrointestinal malignancies: mechanistic insights and translational therapeutic opportunities","volume":"57","author":"Rathod","year":"2026","journal-title":"J. Gastrointest. Cancer"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215251_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.bioadv.2026.215251_bb0055","article-title":"Gallbladder cancer: current and future treatment options","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/cco.2019.06.06","article-title":"Gallbladder cancer: surgical management","volume":"8","author":"Krell","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215251_bb0065","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4251\/wjgo.v13.i10.1317","article-title":"Gallbladder cancer: historical treatment and new management options","volume":"13","author":"Okumura","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/00325481.2024.2345585","article-title":"Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy","volume":"136","author":"Sun","year":"2024","journal-title":"Postgrad. Med."},{"issue":"22","key":"10.1016\/j.bioadv.2026.215251_bb0075","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.3390\/cancers14225580","article-title":"Gallbladder cancer: current multimodality treatment concepts and future directions","volume":"14","author":"Sturm","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215251_bb0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ags3.12434","article-title":"Essential updates 2019\/2020: surgical treatment of gallbladder cancer","volume":"5","author":"Matsuyama","year":"2021","journal-title":"Ann. Gastroenterol. Surg."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215251_bb0085","article-title":"Biliary tract cancer","volume":"51","author":"S\u00f8reide","year":"2025","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Brit. Assoc. Surg. Oncol."},{"issue":"10272","key":"10.1016\/j.bioadv.2026.215251_bb0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/cco.2019.07.02","article-title":"Adjuvant therapy for resected gallbladder cancer","volume":"8","author":"Suzuki","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/intimm\/dxaf065","article-title":"KRAS mutations disrupt interactions between CD8+ T cells and antigen-presenting cells in the tumor microenvironment of biliary tract cancer","volume":"38","author":"Terasaki","year":"2026","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215251_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/md20060349","article-title":"Natural marine products: anti-colorectal cancer in vitro and in vivo","volume":"20","author":"Han","year":"2022","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17460441.2020.1722636","article-title":"Metabolomic tools used in marine natural product drug discovery","volume":"15","author":"Stuart","year":"2020","journal-title":"Expert Opin. Drug Discovery"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s13668-023-00492-x","article-title":"Fucoxanthin, a functional food ingredient: challenges in bioavailability","volume":"12","author":"Fernandes","year":"2023","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.bioadv.2026.215251_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.929442","article-title":"Fucoxanthin: a promising phytochemical on diverse pharmacological targets","volume":"13","author":"Mumu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0125","article-title":"Dihydroartemisinin regulates the apoptosis and growth of colorectal cancer by suppressing DPYSL2 and increasing TF and ACHE","volume":"61","author":"Zhang","year":"2024","journal-title":"Food Biosci."},{"issue":"26","key":"10.1016\/j.bioadv.2026.215251_bb0130","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1080\/10408398.2022.2054932","article-title":"Fucoxanthin from marine microalgae: a promising bioactive compound for industrial production and food application","volume":"63","author":"Sun","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bioadv.2026.215251_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117850","article-title":"Fucoxanthin: a promising compound for human inflammation-related diseases","volume":"255","author":"Liu","year":"2020","journal-title":"Life Sci."},{"issue":"23","key":"10.1016\/j.bioadv.2026.215251_bb0140","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.3390\/ijms21239273","article-title":"Fucoxanthin, a marine-derived carotenoid from brown seaweeds and microalgae: a promising bioactive compound for cancer therapy","volume":"21","author":"M\u00e9resse","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/md20040222","article-title":"Fucoxanthin from algae to human, an extraordinary bioresource: insights and advances in up and downstream processes","volume":"20","author":"Pajot","year":"2022","journal-title":"Mar. Drugs"},{"issue":"8","key":"10.1016\/j.bioadv.2026.215251_bb0150","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.3390\/md13084784","article-title":"Fucoxanthin and its metabolite fucoxanthinol in cancer prevention and treatment","volume":"13","author":"Martin","year":"2015","journal-title":"Mar. Drugs"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215251_bb0155","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/ph17070960","article-title":"Unlocking the green gold: exploring the cancer treatment and the other therapeutic potential of fucoxanthin derivatives from microalgae","volume":"17","author":"Mohamed Abdoul-Latif","year":"2024","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215251_bb0160","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.3390\/md11125130","article-title":"Fucoxanthin: a marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms","volume":"11","author":"Kumar","year":"2013","journal-title":"Mar. Drugs"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215251_bb0165","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.3390\/nu5124978","article-title":"Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis","volume":"5","author":"Rengarajan","year":"2013","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0170","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.21873\/anticanres.11484","article-title":"Antitumor and cancer-preventative function of fucoxanthin: a marine carotenoid","volume":"37","author":"Satomi","year":"2017","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215251_bb0175","first-page":"953","volume":"41","author":"Li","year":"2021","journal-title":"Nan fang yi ke da xue xue bao = J. South. Med. Univ."},{"key":"10.1016\/j.bioadv.2026.215251_bb0180","article-title":"Fucoxanthin prevents breast cancer metastasis by interrupting circulating tumor cells adhesion and transendothelial migration","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/md23030123","article-title":"Fucoxanthin from Laminaria japonica targeting PANoptosis and ferroptosis pathways: insights into its therapeutic potential against ovarian cancer","volume":"23","author":"Wang","year":"2025","journal-title":"Mar. Drugs"},{"issue":"18","key":"10.1016\/j.bioadv.2026.215251_bb0190","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.3390\/molecules28186536","article-title":"Anticancer effects of fucoxanthin through cell cycle arrest, apoptosis induction, and angiogenesis inhibition in triple-negative breast cancer cells","volume":"28","author":"Ahmed","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bioadv.2026.215251_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214600","article-title":"Targeted inhibition of colorectal cancer by nano-dihydroartemisinin liposomes: insights into the disruption of ABCG2 and BCL2 leading to induction of oxidative stress and metabolic disorder","volume":"180","author":"Cao","year":"2026","journal-title":"Biomater. Adv."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2004.07.048","article-title":"Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells","volume":"220","author":"Kotake-Nara","year":"2005","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215251_bb0205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/md20060370","article-title":"Fucoxanthin is a potential therapeutic agent for the treatment of breast cancer","volume":"20","author":"Lau","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioadv.2026.215251_bb0210","first-page":"11","article-title":"Fucoxanthin and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically promotes apoptosis of human cervical cancer cells by targeting PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"24","author":"Jin","year":"2018","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215251_bb0215","first-page":"2528","article-title":"Fucoxanthin suppresses the malignant progression of ovarian cancer by inactivating STAT3\/c-Myc signaling","volume":"15","author":"Zhang","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bioadv.2026.215251_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105746","article-title":"Rapamycin improves the survival of epilepsy model cells by blocking phosphorylation of mTOR base on computer simulations and cellular experiments","volume":"176","author":"Li","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioadv.2026.215251_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1013911","article-title":"Mechanism of N-0385 blocking SARS-CoV-2 to treat COVID-19 based on molecular docking and molecular dynamics","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215251_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/me.2013-1291","article-title":"Minireview: role of orphan nuclear receptors in cancer and potential as drug targets","volume":"28","author":"Safe","year":"2014","journal-title":"Mol. Endocrinol. (Baltimore, Md.)"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jdb12030024","article-title":"Roles of the NR2F family in the development, disease, and cancer of the lung","volume":"12","author":"Yang","year":"2024","journal-title":"J. Develop. Biol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.31083\/j.fbl2801013","article-title":"New insights into the diverse functions of the NR2F nuclear orphan receptor family","volume":"28","author":"Sajinovic","year":"2023","journal-title":"Front. Biosci. (Landmark edition)"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/aps.2014.86","article-title":"The role of the orphan nuclear receptor COUP-TFII in tumorigenesis","volume":"36","author":"Xu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioadv.2026.215251_bb0250","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s44178-026-00279-4","article-title":"Advances in biomimetic nanomaterials for targeted drug delivery in colon cancer","volume":"5","author":"Dharme","year":"2026","journal-title":"Holist. Integ. Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0255","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210836","article-title":"An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy","volume":"219","author":"Khalil","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioadv.2026.215251_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153938","article-title":"The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer","volume":"235","author":"Luo","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bioadv.2026.215251_bb0265","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/ncomms7170","article-title":"NR2F1 controls tumour cell dormancy via SOX9- and RAR\u03b2-driven quiescence programmes","volume":"6","author":"Sosa","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/or.2024.8698","article-title":"Abscisic acid signaling through LANCL2 and PPAR\u03b3 induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells","volume":"51","author":"Parajuli","year":"2024","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215251_bb0275","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1111\/jcmm.14386","article-title":"Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p\/CCND1 axis","volume":"23","author":"Guo","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215251_bb0280","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.3390\/biomedicines13122950","article-title":"The anti-EMMPRIN monoclonal antibody hMR18-mAb induces tumor dormancy and inhibits the EMT process in human carcinoma cell lines co-cultured with macrophages","volume":"13","author":"Simanovich","year":"2025","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0285","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41419-024-06610-z","article-title":"PTEN decreases NR2F1 expression to inhibit ciliogenesis during EGFRL858R-induced lung cancer progression","volume":"15","author":"Tran","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioadv.2026.215251_bb0290","article-title":"A review on the role of NR2F1-AS1 in the development of cancer","volume":"240","author":"Ghafouri-Fard","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215251_bb0295","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/jbmr.4565","article-title":"Metabolic switch under glucose deprivation leading to discovery of NR2F1 as a stimulus of osteoblast differentiation","volume":"37","author":"Lee","year":"2022","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0300","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41419-022-04669-0","article-title":"Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1\/AKT\/mTOR axis","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215251_bb0305","article-title":"Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3","volume":"12","author":"Zuo","year":"2025","journal-title":"Genes Dis."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215251_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011222","article-title":"A Foxf1-Wnt-Nr2f1 cascade promotes atrial cardiomyocyte differentiation in zebrafish","volume":"20","author":"Coppola","year":"2024","journal-title":"PLoS Genet."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215251_bb0315","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/0008-5472.CAN-21-4145","article-title":"NR2F1 is a barrier to dissemination of early-stage breast cancer cells","volume":"82","author":"Rodriguez-Tirado","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0320","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1186\/s40001-025-03332-6","article-title":"Transcriptional activation of MACF1 by NR2F1 drives WNT-mediated focal adhesion and metastasis in lung adenocarcinoma","volume":"30","author":"Zhou","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41419-022-04540-2","article-title":"The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p\/VAMP7 axis","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215251_bb0330","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13058-018-1049-0","article-title":"NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients","volume":"20","author":"Borgen","year":"2018","journal-title":"Breast Cancer Res. BCR"},{"issue":"19","key":"10.1016\/j.bioadv.2026.215251_bb0335","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.3390\/cancers14194639","article-title":"NR2F1 regulates TGF-\u03b21-mediated epithelial-mesenchymal transition affecting platinum sensitivity and immune response in ovarian cancer","volume":"14","author":"Liang","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215251_bb0340","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2174\/0113894501434141251223120435","article-title":"Targeting the cGAS-STING pathway in gastrointestinal cancers: modulating tumor-associated inflammation for therapeutic effect","volume":"27","author":"Rathod","year":"2026","journal-title":"Curr. Drug Targets"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215251_bb0345","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3390\/cancers14122962","article-title":"NR2F1, a tumor dormancy marker, is expressed predominantly in cancer-associated fibroblasts and is associated with suppressed breast cancer cell proliferation","volume":"14","author":"Wu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioadv.2026.215251_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106604","article-title":"Mitochondrial regulation of adult hippocampal neurogenesis: insights into neurological function and neurodevelopmental disorders","volume":"199","author":"Bonzano","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215251_bb0355","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049854","article-title":"NR2F1 shapes mitochondria in the mouse brain, providing new insights into Bosch-Boonstra-Schaaf optic atrophy syndrome","volume":"16","author":"Bonzano","year":"2023","journal-title":"Dis. Model. Mech."},{"issue":"9\u201310","key":"10.1016\/j.bioadv.2026.215251_bb0360","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1242\/dmm.004648","article-title":"Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress","volume":"3","author":"Cho","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bioadv.2026.215251_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177964","article-title":"Cuproptosis induced by curcumin interfering with proliferation and energy metabolism in colorectal cancer: 3D tumor model and computational simulations reveal curcumin inhibition of HSPD1 and CALCOCO2","volume":"1003","author":"Cao","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioadv.2026.215251_bb0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2022.11.003","article-title":"Mitochondrial permeability transition pore-dependent necrosis","volume":"174","author":"Robichaux","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bioadv.2026.215251_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108729","article-title":"Dihydroartemisinin suppresses metastatic potential and induces apoptosis in gastric adenocarcinoma: an integrative experimental and computational analysis revealing inhibition of MMP14 and promotion of oxidative stress","volume":"163","author":"Cao","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioadv.2026.215251_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4350965","article-title":"ROS and ROS-mediated cellular signaling","volume":"2016","author":"Zhang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0385","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioadv.2026.215251_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1601908","article-title":"Mechanistic insights curcumin's anti-inflammatory in pancreatic cancer: experimental and computational evidence implicating IL1B interference via IL10RA upregulation and NLRP3\/TLR3 downregulation","volume":"13","author":"Cao","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215251_bb0395","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/jcmm.14151","article-title":"Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer","volume":"23","author":"Wang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioadv.2026.215251_bb0400","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/768323","article-title":"Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae","volume":"2014","author":"Zorofchian Moghadamtousi","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.bioadv.2026.215251_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104830","article-title":"Dietary carotenoids in cancer chemoprevention and chemotherapy: a review of emerging evidence","volume":"157","author":"Saini","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826005510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826005510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:24:19Z","timestamp":1793694259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826005510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":81,"alternative-id":["S2772950826005510"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215251","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylated fucoxanthin liposomes remodel G0\/G1 cell cycle homeostasis and suppress gallbladder cancer progression via modulation of NR2F1-mediated signaling networks","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215251"}}